Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aldosterone
100%
Low-density Lipoprotein
100%
Hypertension
33%
Aldosterone Levels
16%
Phospholipase D2 (PLD2)
16%
Lipoprotein Levels
16%
Lipid Components
11%
Congestive Heart Failure
11%
Obesity
11%
Diet-induced Obesity
11%
Glomerular Mesangial Cells
11%
Aldosterone Secretion
11%
Excess Weight
11%
Overweight/obesity
5%
Lean Individuals
5%
Ablation
5%
Stimulatory Effect
5%
Mineralocorticoid
5%
Possible Mechanisms
5%
Sodium Balance
5%
Human Disease
5%
Gene Encoding
5%
Knock-in Mouse Model
5%
Dyslipidemia
5%
Human Body
5%
Overexpression
5%
Adrenal Gland
5%
CYP11B2
5%
Signaling Pathway
5%
High Blood Pressure
5%
Angiotensin II Infusion
5%
Active Agent
5%
RNA Interference
5%
Attendants
5%
Specific Aims
5%
Knock
5%
Signal Transduction Pathway
5%
Electrolyte
5%
Physiological Concentrations
5%
Aldosterone Synthase
5%
Signaling Molecules
5%
Active Components
5%
Lipids
5%
Lipoprotein Lipids
5%
Zona Glomerulosa
5%
Veteran Population
5%
Model in Vitro
5%
Lipidomics
5%
Biochemistry, Genetics and Molecular Biology
Very Low-Density Lipoprotein
100%
Aldosterone
100%
Phospholipase
16%
Lipid
16%
Aldosterone Release
11%
Aldosterone Synthase
11%
Signal Transduction
5%
Mouse Model
5%
Blood Pressure
5%
Agonist
5%
Mineralocorticoid
5%
Sodium Balance
5%
Lipidomics
5%
Knockout Mouse
5%
Dyslipidemia
5%
Signaling Mechanism
5%
Secretion (Process)
5%
Angiotensin
5%
RNAI
5%